 This research has shown that the translocation of BATV2 from the nucleus to the cytoplasm is associated with poorer survival rates in colorectal cancer patients. It also suggests that this process could be used as a target for future treatments. This article was authored by Ji Zhu, Zheng Ji Lei, Qian Fang Chen, and others.